In the Media

Wall Street Journal reporter David Wainer spotlights a 2021 study conducted Prof. Andrew Lo and his colleagues that investigated “what happened to innovation when drug companies were no longer able to resort to one of their favorite tactics: paying generic makers to stay off the market.”